ArticleCureus2023
Isolated Facial Diplegia: A Rare Presentation of Guillain-Barré Syndrome.
Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 2 citations in OpenAlex.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Guillain-Barré syndrome is an autoimmune condition typically characterized by progressive areflexic ascending motor deficit and paresthesia. However, atypical presentations, such as isolated facial diplegia, are rare and diagnostically challenging. We describe a unique case of Guillain-Barré syndrome in a 46-year-old male patient, presenting as isolated bilateral facial paralysis without preceding medical history. Symptoms included tongue heaviness, loss of taste, dysarthria, and inability to close eyelids. A neurological examination confirmed bilateral facial paralysis. Laboratory tests and cerebrospinal fluid analyses were unremarkable, except for albumin-cytological dissociation. Electromyography revealed severe demyelinating damage to facial nerves. The patient responded well to intravenous immunoglobulin therapy. This case highlights the necessity of considering Guillain-Barré syndrome in patients with isolated facial diplegia. A thorough clinical evaluation, supported by laboratory and electromyographic findings, is crucial for accurate diagnosis and effective treatment. Early identification and intervention are key for optimal outcomes in these atypical presentations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.